title: Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use.
authors.forename: A
authors.initials: A
authors.lastname: Zullo
authors.forename: C
authors.initials: C
authors.lastname: Hassan
authors.forename: S
authors.initials: S
authors.lastname: Morini
authors.forename: V
authors.initials: V
authors.lastname: De Francesco
authors.forename: E
authors.initials: E
authors.lastname: Ierardi
authors.forename: C
authors.initials: C
authors.lastname: Panella
authors.forename: L
authors.initials: L
authors.lastname: Gatta
authors.forename: D
authors.initials: D
authors.lastname: Vaira
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001729:Bismuth / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D011899:Ranitidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
chemical_list: D000897:Anti-Ulcer Agents; C073340:ranitidine bismuth citrate; D011899:Ranitidine; D001729:Bismuth